MicroMediom Pitches at 'KDB NextRound' IR Event
top of page
News Room
Search
KDB NextRound is a startup IR (Investor Relations) event organized by Korea Development Bank (KDB). This event featured IR presentations...
MicroMediom Wins Prestigious K-R&D Award for Microbiome Research
MicroMediom, a start-up founded by professors from Korea University College of Medicine, has been honored with the K-R&D Award at the...
Excellence in Innovation: Celebrating Our Project's Success in 2023
We are thrilled to announce that our project has been awarded the prestigious honor for exceptional performance and contribution in 2023....
MicroMediome Donates 10.4 Million Won to Seongbuk-gu Dream Start
Seoul – MicroMediome, a company based in Korea University Campus Town, announced on the 22nd that it has donated goods worth 10.4 million...
[2023 Korea University Campus Town Startup CEO] ‘Micromediome’, a startup conducting research using
MicroMediome is a startup that conducts research in the fields of oncology treatment, vaccines, drug delivery systems, and more,...
Micromediome has attracted seed investment.
In June 2023, Micromediome successfully secured a seed investment of 300 million KRW from Synergy IB Corporation.
Uijeongbu City, Participated in Bio Cluster Creation Working Group
의정부시, 바이오클러스터 조성 워킹그룹 신설참여 2023.2.26 https://www.etnews.com/20230226000126
Microbiome commercialization status and prospects
마이크로바이옴 상용화 현황 및 전망 : 과학기술정보통신부 바이오아이코어사업단 강의 2023.02. https://www.youtube.com/watch?v=FDJjS3WOwdo
bottom of page